Explore the Agenda

8:00 am Registration & Coffee

8:50 am Chair’s Opening Remarks

Developing Practical, Risk-Based Strategies to Build Scalable & Resilient Raw Material Control Across Development Stages

9:00 am Panel Discussion: Building a Robust Raw Material Strategy for Advanced Therapies

Chief Technology Officer, Aspen Neuroscience
Independent Raw Materials Expert & USP CGT Expert Committee Member, biomatria
  • Establishing a phase-appropriate raw material strategy that supports both early development flexibility and late-stage regulatory expectations
  • Navigating evolving regulatory expectations for raw materials
  • Evaluating supplier strategies, including sole vs dual sourcing, to mitigate supply chain risk while maintaining product comparability and regulatory compliance

9:45 am AAV Gene Therapy Case Study: Building an Overall Raw Material Control Strategy

Associate Director, MS&T, Ray Therapeutics
  • Setting up a simple and structured raw material risk approach suitable for small and growing organizations
  • Prioritizing testing and qualification effort when time, data, and resources are limited
  • Assessing risk early to avoid downstream delays and rework

10:15 am Morning Break & Speed Networking

Accelerating Development Timelines Through Phase Appropriate Material Qualification That Balances Speed with Robust Quality

11:15 am Balancing Quality with Speed & Efficiency to Create a Phase Appropriate Material Qualification Strategy

Technical Development Scientist II, Genentech
  • Qualifying multiple materials to enable parallel testing during early development
  • Aligning early-stage work with the requirements for transfer into stage two
  • Balancing speed with quality to support a reliable and effective transition

11:45 am Roundtable Discussion: Building Risk Based Raw Material Strategies for Complex CGT Manufacturing

Associate Director, Raw Material Quality, Fate Therapeutics
  • Exploring how companies prioritize raw materials using risk-based frameworks
  • Comparing approaches to material qualification, sampling strategies, and CoA expectations
  • Discussing regulatory experiences shaping raw material decisions across development stages

12:30 pm Lunch Break & Networking

Private lunch hosted by Instant Systems, please inquire at info@hansonwade.com for more information

Using Data to Define Variability Acceptance Limits & Material Qualification Decision Making

1:30 pm Reducing Process Risk by Defining the Variability You Can Still Proceed With

Associate Director, Cabaletta Bio
  • Defining acceptance criteria based on process characterization rather than supplier specifications
  • Understanding when variability can be absorbed and when it becomes a process risk
  • Disqualifying lots with confidence using data instead of assumptions

2:00 pm Audience Discussion: Benchmark Your Approach to Variability Management

This interactive session will create space for peer-to-peer exchange on how teams are managing raw material variability, qualification, and process risk in practice. Through structured discussions, attendees will share approaches, compare challenges, and explore how to make more confident, data led decisions across development stages.

  • Exploring approaches to defining and managing acceptable material variability
  • Comparing strategies for material qualification and release decisions
  • Sharing practical insights on using data to improve confidence and reduce process risk

2:45 pm Afternoon Break & Poster Session

Turning Material Failures into Stronger Strategies to Improve Resilience & Decision Making Across Complex Supply Chains

3:45 pm When Materials Fail: How Risk Ranking & Supplier Engagement Transformed Our Strategy

Associate Director, Raw Materials, Drug Product Process Development, Bristol Myers Squibb
  • Turning raw material failures into a catalyst – redefining supplier strategy through a centralized, data-driven MRC model
  • Applying integrated risk scoring (beyond PRAM) to pinpoint and prioritize highest-risk suppliers
  • Deployment of targeted technical due diligence visits to shift from reactive firefighting to proactive risk mitigation

4:15 pm Review & Reflect: Consolidating Key Learnings from Day One

This interactive working session brings together the key discussion points surfaced across the day’s presentations to explore where approaches align and where they differ. In small groups, you’ll examine shared challenges across raw material selection, qualification, and control, drawing on real-world experience from across functions including QC, MSAT, and supply chain. The session will close with group feedback to capture collective insights, helping you refine your approach and carry forward key learnings into day two.

4:45 pm End of Day One